| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2011 | WO2011089951A1 Prevention/treatment agent for diabetic retinopathy and foodstuff aiming to prevent/treat diabetic retinopathy, ameliorating agent for various symptoms of diabetic retinopathy and foodstuff aiming to ameliorate various symptoms of diabetic retinopathy, and method for determining dosing period of prevention/ameliorating agent for diabetic retinopathy |
| 07/28/2011 | WO2011089614A1 PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM |
| 07/28/2011 | WO2011089576A2 NOVEL COMPOSITIONS FOR REDUCING Aß 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD) |
| 07/28/2011 | WO2011089561A1 Methods for producing amino-substituted glycolipid compounds |
| 07/28/2011 | WO2011089559A1 A novel polymorphic form of atorvastatin salts |
| 07/28/2011 | WO2011089550A1 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application |
| 07/28/2011 | WO2011089529A1 Salicylate fatty acid derivatives |
| 07/28/2011 | WO2011089509A1 A process for the preparation of novel porphyrin derivatives and their use as pdt agents and fluorescence probes |
| 07/28/2011 | WO2011089507A1 A new series of artemisinin derivatives and process for preparation thereof |
| 07/28/2011 | WO2011089457A1 Novel medicinal compounds |
| 07/28/2011 | WO2011089456A1 Novel medicinal compounds |
| 07/28/2011 | WO2011089446A1 Use of pharmaceutically active compounds |
| 07/28/2011 | WO2011089416A1 Pyrazine derivatives |
| 07/28/2011 | WO2011089401A1 Crystalline forms of a purine derivative |
| 07/28/2011 | WO2011089400A1 Inhibitors of pi3 kinase |
| 07/28/2011 | WO2011089395A1 Antiseptic chewing gum |
| 07/28/2011 | WO2011089289A1 Use of amitriptyline as antitumour agent for the treatment of lung cancer |
| 07/28/2011 | WO2011089265A1 Use of fatty acid compounds for lowering blood glucose levels |
| 07/28/2011 | WO2011089261A1 Use of hydrogels on the basis of guluronic acid- and/or mannuronic acid-containing polysaccharides for treating damage to the nervous system, promoting nerve growth, treating neurodegenerative diseases and cultivating neurons |
| 07/28/2011 | WO2011089234A2 Method and composition |
| 07/28/2011 | WO2011089173A1 Hydrogel of microspheres |
| 07/28/2011 | WO2011089168A2 Special composition for the use thereof as a drug |
| 07/28/2011 | WO2011089167A1 Kombination of proteasome inhibitors and anti -hepatitis medication for treating retroviral diseases |
| 07/28/2011 | WO2011089161A1 Pharmaceutical compositions comprising lignans and their derivatives for the medical management of angiogenesis and hypovascularity |
| 07/28/2011 | WO2011089132A1 Nitrogen-containing heteroaryl derivatives |
| 07/28/2011 | WO2011089126A2 Novel composition |
| 07/28/2011 | WO2011089099A1 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/28/2011 | WO2011088843A1 Enterococcal cell wall components and antibacterial use thereof |
| 07/28/2011 | WO2011088838A1 Novel 6,6a,7,8,9,10-hexahydro-4h-4,8,10a-triaza-acephenanthrylene derivatives as dopamine d2 ligands |
| 07/28/2011 | WO2011088836A1 NOVEL 4-(ARYL-4-SULFONYL)-6,6a,7,8,9,10-HEXAHYDRO-4H-4,8,10a-TRIAZA-ACEPHENANTHRYLENE AND 3-ARYLSULFONYL-6,6a,7,8,9,10-HEXAHYDRO-3H-3,8,10a-TRIAZA-CYCLOPENTA[C]FLUORENE DERIVATIVES AS SEROTONIN 5-HT6 LIGANDS |
| 07/28/2011 | WO2011088820A1 Solid pharmaceutical composition comprising lercanidipine |
| 07/28/2011 | WO2011088806A2 A method of industrial production of an amorphous form of atorvastatin with a high specific surface area and its use in a dosage form |
| 07/28/2011 | WO2011088745A1 Ophthalmic external antibacterial medicine |
| 07/28/2011 | WO2011088715A1 Use of albiflorin for anti-parkinson's disease |
| 07/28/2011 | WO2011088605A1 Use of leptin in enhancing therapeutic efficacy of medroxyprogesterone acetate on liver cancer |
| 07/28/2011 | WO2011088561A1 Anti-viral compounds and compositions |
| 07/28/2011 | WO2011088553A1 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
| 07/28/2011 | WO2011088550A1 Pharmaceutical formulations of loratadine for encapsulation and combinations thereof |
| 07/28/2011 | WO2011088549A1 Derivatives of pyridoxine for inhibiting hiv integrase |
| 07/28/2011 | WO2011088536A1 Use of at least one isoquinoline compound of formula i, pharmaceutical composition for treating or preventing neurodegenerative diseases and method for treating or preventing neurodegenerative diseases |
| 07/28/2011 | WO2011088532A1 Pharmaceutical compositions for the treatment of bacterial infections |
| 07/28/2011 | WO2011088525A1 A diagnostic test |
| 07/28/2011 | WO2011088524A1 Methods for regulating blood glucose levels |
| 07/28/2011 | WO2011088504A1 Methods and compositions for improved nerve conduction velocity |
| 07/28/2011 | WO2011088503A1 Anaesthetic formulation |
| 07/28/2011 | WO2011069159A3 Bis[thiohydrazide amide] compounds for treating leukemia |
| 07/28/2011 | WO2011069075A3 Treating impulse control disorders with catechol-o- methyl-transferase inhibitors |
| 07/28/2011 | WO2011069010A3 Amantadine compositions and methods of use |
| 07/28/2011 | WO2011060065A3 Instillation of liposomal formulation of sirna and antisense oligonucleotides |
| 07/28/2011 | WO2011056961A3 Method and compositions for suppression of aging |
| 07/28/2011 | WO2011054939A3 Compositions and methods for inhibiting expression of kif10 genes |
| 07/28/2011 | WO2011049706A9 Orally transformable tablets |
| 07/28/2011 | WO2011045810A4 Pharmaceutical compositions containing taurine and race-methionine for the treatment of alcoholism |
| 07/28/2011 | WO2011038160A3 Compositions and methods for silencing genes expressed in cancer |
| 07/28/2011 | WO2011038152A3 Toll-like receptor modulators and uses thereof |
| 07/28/2011 | WO2011035005A3 Compositions and methods for reducing the risk of agent-induced liver toxicity |
| 07/28/2011 | WO2011034962A3 Compounds that modulate intracellular calcium |
| 07/28/2011 | WO2011031327A3 Nicotine haptens, immunoconjugates and their uses |
| 07/28/2011 | WO2011022596A3 Preparation of bazedoxifene and its salts |
| 07/28/2011 | WO2011017516A3 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 07/28/2011 | WO2010149378A3 Diastereomeric and enantiomeric tricyclic compounds and method for producing diastereomeric and enantiomeric bicyclic and tricyclic compounds |
| 07/28/2011 | WO2010138598A3 Lxr modulators |
| 07/28/2011 | WO2010119300A9 Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone |
| 07/28/2011 | WO2010111599A3 Compositions and methods for treatment of renal disease |
| 07/28/2011 | WO2010088544A8 Methods to treat cancer |
| 07/28/2011 | WO2009007660A9 Liquid or paste compositions intended to provide elements essential for the synthesis and formation of proteoglycans, in particular, for the treatment of cartilage degradation |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184379 Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools |
| 07/28/2011 | US20110184358 Pulsatile peri-corneal drug delivery device |
| 07/28/2011 | US20110184333 Photolabile caged transition metal complexes and methods of using the same |
| 07/28/2011 | US20110184220 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 07/28/2011 | US20110184072 Formulation intended to improving the bioavailability of a hydrophobic molecule |
| 07/28/2011 | US20110184071 process for the preparation of amines |
| 07/28/2011 | US20110184070 Novel compounds, use thereof as medicaments, and method of preparation thereof |
| 07/28/2011 | US20110184069 Methods and compositions for administration of trpv1 agonists |
| 07/28/2011 | US20110184068 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 07/28/2011 | US20110184067 O-desmethylvenlafaxine succinate polymorph & process for preparing thereof |
| 07/28/2011 | US20110184066 Ketoprofen Lysine Salt-Containing Aqueous Patch |
| 07/28/2011 | US20110184065 Use of spongosine for the treatment of pain |
| 07/28/2011 | US20110184064 Therapeutic agent for hepatitis c |
| 07/28/2011 | US20110184063 Treatment of neurodegenerative conditions |
| 07/28/2011 | US20110184062 Compositions and methods for dry eye syndrome |
| 07/28/2011 | US20110184061 Thiocolchicine and colchicine analogs, methods of making and methods of use thereof |
| 07/28/2011 | US20110184060 Oral dosage forms having a high loading of a tranexamic acid prodrug |
| 07/28/2011 | US20110184059 Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions |
| 07/28/2011 | US20110184058 Synthesis of 6,7-dihydro-1h-indeno[5, 4-b] furan-8(2h)-one as intermediate in the preparation of remelteon |
| 07/28/2011 | US20110184057 Parenteral treatment with statins |
| 07/28/2011 | US20110184056 Use of statins as anticonvulsants, antiepileptics and neuroprotectors |
| 07/28/2011 | US20110184055 Therapeutic agents for treatment of ocular hypertension |
| 07/28/2011 | US20110184054 Alpha-lipoic acid concentrate |
| 07/28/2011 | US20110184053 Novel nucleic acid transfer system |
| 07/28/2011 | US20110184052 Arginase ii: a target for the prevention and treatment of atherosclerosis |
| 07/28/2011 | US20110184051 Pharmacological applications of mitochondrial dna assays |
| 07/28/2011 | US20110184050 Methods and means for treating dna repeat instability associated genetic disorders |
| 07/28/2011 | US20110184047 Rnai modulation of scap and therapeutic uses thereof |
| 07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 07/28/2011 | US20110184045 Silencng and rig-i activation by dual function oligonucleotides |
| 07/28/2011 | US20110184044 Methods and compositions for assessment of pulmonary function and disorders |
| 07/28/2011 | US20110184043 Inhibition of angiogenesis |
| 07/28/2011 | US20110184042 RNA Aptamer Specifically Binding to Carcinoembryonic Antigen and Use thereof |